• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra

    2018-05-05 06:47:11JunFangChenManWangYingHanZhuangThomasBehnisch

    Jun-Fang Chen, Man Wang, Ying-Han Zhuang, Thomas Behnisch

    The Institutes of Brain Science, the State Key Laboratory of Medical Neurobiology, and the Collaborative Innovation Center for Brain Science,Fudan University, Shanghai, China

    Introduction

    Parkinson’s disease is a neurodegenerative disorder characterized by the progressive degeneration of nigrostriatal dopaminergic neurons (Kong et al., 2008; Jung et al., 2014).To generate subchronic or chronic Parkinson’s disease-like mouse models, the intraperitoneal administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) has been widely used (Petroske et al., 2001; Zhu et al., 2011; Paul et al., 2017). MPTP induces neurodegeneration of dopaminergic neurons, resulting in motor impairments (Santos et al., 2017) that are similar to those in Parkinson’s disease patients. MPTP needs to be converted to 1-methyl-4-phenylpyridinium ion (MPP+) by glial monoamine oxidase B and be taken up into dopaminergic neurons by dopamine transporter (Espinosa-Oliva et al., 2014; Geed et al., 2014) to exert its cytotoxic effects (Schmidt and Ferger, 2001; Binukumar and Pant, 2016). Thus, administration of MPP+is widely used for the generation of Parkinson’s disease-like symptoms in mice (Petroske et al., 2001; Geed et al., 2014; Santos et al., 2017) and rats (Sonsalla et al., 2008).Because MPP+cannot freely traverse the blood-brain barrier, it has to be administrated into the brain by stereotaxic intracerebroventricular injection. In addition, this mode of MPP+administration avoids the detrimental peripheral effects of systemic intraperitoneal MPTP administration (Sonsalla et al., 2008). Depending on the dose and frequency of administration, different degrees of neuronal degeneration can be achieved (Petroske et al., 2001). The degeneration of dopaminergic neurons is also accompanied by the degeneration of dopaminergic projections from the substantia nigra(SN) and ventral tegmental area in the striatum (Bellucci et al., 2017; Kalia, 2018). Only recently have other brain areas,such as the hippocampus, been recognized as contributing to motor or non-motor deficits in Parkinson’s disease (Kohl et al., 2016; Liu et al., 2018; Medina, 2018). Many non-motor symptoms in Parkinson’s disease patients, such as fatigue,anxiety, depression and dementia, have been linked to altered catecholamine levels in the hippocampus (Pfeiffer,2016). Dopamine is released in the septotemporal axis of the hippocampus, from axon terminals originating from the ventral tegmental area and the SN (Gasbarri et al., 1997).Surprisingly, dopaminergic terminals and dopamine receptors in the hippocampus are anatomically distant from each other, leading to the notion that noradrenergic terminals from the locus coeruleus innervating the hippocampus and the dentate gyrus (DG) are capable of releasing dopamine under certain conditions (Smith and Greene, 2012). Anti-tyrosine hydroxylase (TH) staining labels nerve terminals of dopaminergic and noradrenergic neurons, revealing a dense network of catecholaminergic nerve terminals within the entire hippocampus, of which only a few are dopaminergic(Smith and Greene, 2012). A reduction in TH-positive nerve terminals in the striatum correlates with a reduction in dopamine content (Santiago et al., 2001); however, evaluation of norepinephrine levels after application of neurotoxins is rare. In addition, a change in TH-positive nerve terminals innervating the hippocampus after intracerebroventricular administration of the neurotoxin MPP+has not yet been documented.

    We are interested in whether a single administration of MPP+evokes a compensatory increase in neurogenesis within the subgranular zone (SGZ) of the DG (Danielson et al., 2016) and SN (Mao and Wang, 2003). Previous studies have shown that adult neurogenesis in the DG is strongly associated with mood and cognitive functions, and that an imbalance in neurogenesis and cell death possibly leads to non-motor symptoms (Marxreiter et al., 2013; Salvi et al.,2016; Ermine et al., 2018; Farzanehfar, 2018). To resolve this misbalance, neurotrophic factors, such as fi broblast growth factor and brain-derived neurotrophic factor (BDNF), have been studied for their ability to enhance neuronal proliferation and differentiation (Lee et al., 2010; Hu et al., 2013).Indeed, endogenous neurogenesis in neuroproliferative zones in the adult brain is enhanced by administration or overexpression of growth factors, including BDNF (Pencea et al., 2001), epidermal growth factor and fibroblast growth factor 2 (Peng et al., 2008). However, it remains unclear whether cell death induced by single-dose MPP+alters neurogenesis or whether single-dose BDNF impacts the effect of the neurotoxin.

    Here, we investigate the effects of a single intracerebroventricular MPP+administration on TH-positive nerve terminals in the hippocampus and striatum as well as on neurogenesis in the SGZ and substantia nigra 6 days later. In addition, we examine the impact of intracerebroventricular infusion of BDNF after the acute MPP+administration.

    Materials and Methods

    Animals

    Forty male C57BL/6 mice, aged 6–7 weeks and weighing 20–24 g, were obtained from the Animal Center of the Chinese Academy of Sciences (Shanghai, China) and SLAC Laboratory Animal Co., Ltd. (Shanghai, China) and maintained in accordance with the established standards of animal care and procedures of the Institutes of Brain Science and State Key Laboratory of Medical Neurobiology (approval No.31320103906; Fudan University, Shanghai, China). Efforts were made to minimize the number of animals used (Zhu et al., 2012).

    Surgical procedure and treatments

    Mice, intraperitoneally anesthetized with chloral hydrate(300 mg/kg; Sigma-Aldrich, St. Louis, MO, USA), were positioned in a stereotaxic apparatus (Stoelting, Wood Dale, IL,USA) (Wang et al., 2017). A guide cannula was implanted into the right lateral ventricle, 0 mm posterior to the bregma, 1 mm right of the midline and 2.25 mm deep, and fixed with jeweler’s acrylic cement. The coordinates were determined according to a mouse brain stereotaxic atlas (Pencea et al., 2001; Valvassori et al., 2015). After surgery, mice were allowed 2–3 days for recovery. On the day of administration,a smaller cannula was placed into the guide cannula so that its tip protruded 0.5 mm. The new cannula was connected to a microsyringe by a polyethylene tube. The compounds were applied at a rate of 0.3 μL/min. A schematic of the intracerebroventricular injection position within the brain and the cannula system is presented in Figure 1. Mice were randomly allocated to the saline, MPP+, MPP+/BDNF and BDNF groups. The saline group received ice-cold artificial cerebrospinal fluid (2 μL) in normal saline. The MPP+group received 0.6, 0.6 and 0.8 μL of a 50 mM MPP+iodide solution (100 nmol/2 μL; Sigma-Aldrich), intracerebroventricularly, at 2-hour intervals (Steffen et al., 1995). To determine if the intracerebroventricular administration of BDNF alters the effects of MPP+, the MPP+/BDNF group was given human recombinant BDNF (100 ng/μL in artificial cerebrospinal fluid; Invitrogen, Carlsbad, CA, USA) 1 day after MPP+treatment (Figure 1). The BDNF group was treated with BDNF 1 day after saline injection (Pencea et al., 2001; Benmansour et al., 2008; Deltheil et al., 2009; Valvassori et al.,2015).

    To detect proliferating cells, bromodeoxyuridine (BrdU;Sigma-Aldrich) was used as a mitotic marker. Each animal received three intraperitoneal injections of BrdU (50 mg/kg body weight, for a total of 150 mg/kg) every 9 hours, and were transcardially perfused 9 hours after the last injection(Peng et al., 2008; Schlachetzki et al., 2016).

    Preparation of brain sections

    Mice were anesthetized with chloral hydrate and perfused transcardially with 4% (w/v) paraformaldehyde in 0.01 M phosphate-buffered saline (PBS) (pH 7.3), 7 days after saline or MPP+injection (Figure 1A). The brains were isolated and fixed in 4% paraformaldehyde at 4°C for 24 hours, and then rinsed with 0.01 M PBS and transferred to a 30% sucrose solution in 0.01 M PBS for 3 days. Sagittal sections, 30 μm in thickness, were prepared, and free- floating sections were stored in a cryopreservative solution (30% w/v sucrose, 30%v/v ethylene glycol in 0.01 M PBS) at ?20°C for 24 hours.

    Immunohistochemistry

    After 1 day of cryopreservation, sections were incubated in 1% H2O2in 0.01 M PBS for 15 minutes, followed by blocking solution (0.01 M PBS containing 5% goat serum, 0.3%Triton X-100 and 0.1% bovine serum albumin) for 2 hours at room temperature. After that, sections were incubated with a rabbit monoclonal anti-TH antibody (1:1000; AB152,Chemicon, China) at 4°C overnight. Sections were washed three times with PBS, and incubated with biotinylated goat anti-rabbit secondary antibody (1:500; Vector Laboratories,Burlingame, CA, USA) for 2 hours at 25°C. Immunoreactivity was visualized with the avidin-biotin peroxidase complex(Vectastain Elite ABC kit; Vector Laboratories) and 0.05%diaminobenzidine (Sigma) and 0.03% H2O2. Sections were washed, dehydrated, cleared in xylene, and coverslipped with permanent mounting medium (ProLong Gold Antifade Mountant with DAPI; Invitrogen), and images are shown in Figure 4. Briefly, to measure TH levels in the striatum, the mean staining intensity in an area of the striatum proximal to the ventricle was normalized to the mean intensity in an adjacent region.

    Immuno fluorescence

    Immunofluorescence was performed as described previously (Park and Enikolopov, 2010; Wang et al., 2017).Briefly, 1 day after cryosection, sections were incubated in 2 M HCl at 37°C for 30 minutes, and neutralized with 0.1 M boric acid, pH 8.5, at room temperature for 10 minutes.The sections were washed three times with 0.01 M PBS and incubated with blocking solution (0.01 M PBS containing 1% bovine serum albumin, 5% normal goat serum and 0.3%TritonX-100) for 2 hours. The sections were then treated with the following primary antibodies diluted in blocking solution at 4°C overnight: rat anti-BrdU (1:100; OBT0030S,Accurate Chemical) and rabbit anti-TH (1:500; AB152,Chemicon). After washing, the sections were incubated with secondary antibodies (1:500; Alexa Fluor 488, 546 or 555-conjugated; Thermo Fisher Scientific), diluted in 0.01 M PBS containing 5% normal goat serum, for 2 hours. The sections were post- fixed in 4% paraformaldehyde for 1 hour,washed, and incubated in DAPI (100 ng/mL, Roche) for 1 hour. Sections were then washed and mounted with Fluoromount Aqueous Mounting Medium (Sigma-Aldrich).

    The sections were imaged by fluorescence microscopy(5× and 10× objectives; Olympus, Tokyo, Japan) and confocal microscopy (20× objective; Nikon A1 MP+/A1R MP+,Nikon, Tokyo, Japan). As described above, dopaminergic cell bodies in the SN and TH-positive nerve terminals in the striatum and hippocampus were labeled with antibodies against TH and BrdU. After determining the area of the DG and SN, the total number of labeled cells in every sixth coronal section of the region spanning bregma ?0.5 mm to ?2.0 mm was counted, then multiplied by six to obtain the estimated total number of positive cells per region. For the region of the striatum mainly containing TH-positive nerve terminals, the optical density of TH-immunoreactive fibers was determined by measuring 100 × 100 squares with ImageJ software (National Institutes of Health). The TH-positive fiber density in the striatum was corrected for the nonspecific background density, which was measured in the completely denervated parts surrounding the striatum and presented as the intensity ratio between the striatum in close proximity of the lateral ventricle and the rest of the striatum (Kim et al., 2005). The TH-positive fiber network in the hippocampus was analyzed by manually counting the number of crossings by TH-positive fibers of a line placed parallel to the cell body layer in the DG, CA3 and CA1 areas.The lines covered the dendritic areas of the CA3 and CA1 areas, and the hilus of the DG. The number of crossings was normalized to 100 μm.

    Western blot assay

    Mice were sacrificed 7 days after MPP+injection, as shown in Figure 1A. Western blot assay was performed as described previously (Dong et al., 2013; Huang et al., 2015;Wang et al., 2017). In brief, after anesthesia with isoflurane,brains were removed and immersed in pre-oxygenated (95%O2/5% CO2) ice-cold artificial cerebrospinal fluid (composition in mM: 119 NaCl, 2.5 KCl, 2.5 CaCl2?2H2O, 1.3 MgCl2?7H2O, 1.0 NaH2PO4, 11.0 glucose, 26.2 NaHCO3, pH 7.4). A piece of the entorhinal cortex was sliced off, and the two hemispheres were glued at the midline on the slicing platform of the sectioning system. Transverse hippocampal slices (350 μm) were cut and then snap frozen in liquid nitrogen and stored at ?80°C.

    Figure 1 Illustration of the sequence of MPP+,BDNF and BrdU administration, the single-tube system for drug delivery, and the location of the cannula.

    Figure 2 Distribution of TH-positive nerve terminals in the hippocampal formation.

    Figure 3 Intracerebroventricular administration of MPP+ significantly reduces TH levels in the hippocampal formation within 6 days.

    Figure 4 Effects of BDNF and MPP+ on TH levels in striatal nerve terminals and the number of dopaminergic cells in the SN.

    Figure 5 Confocal fluorescence images of BrdU-positive cells and their quantitative analysis in the SGZ, dentate gyrus and substantia nigra.

    The frozen slices were thawed and then homogenized in radioimmunoprecipitation assay lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 1% Triton X-100, 0.1% aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate and 25 mM sodium fluoride, pH 7.4) supplemented with a protease and phosphatase inhibitor cocktail (Roche,Mannheim, Germany). The concentration of total proteins was measured using a bicinchoninic acid assay kit (Beyotime Institute of Biotechnology, Haimen, Jiangsu Province,China). The samples (30 μg per lane) were separated by 12%sodium dodecyl sulfate polyacrylamide gel electrophoresis and electroblotted onto polyvinylidene fluoride membranes(Immobilon-P, Millipore, Billerica, MA, USA) using the Mini-PROTEAN Tetra System and the Mini Trans-Blot Electrophoretic Transfer System (BioRad, Hercules, CA,USA). The membranes were then incubated with primary antibodies overnight at 4°C after 2 hours of blocking in 5%nonfat milk at room temperature. The primary antibodies were anti-TH (1:1000; AB152, Chemicon) and anti-actin(1:1000; #4970S, Cell Signaling Technology). After washing in Tris-buffered saline-Tween 20, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10,000; 111-035-003, Jackson ImmunoResearch, West Grove, PA, USA) at ambient temperature for 2 hours. The blots were thereafter incubated with enhanced chemiluminescence reagent (Thermo Scientific, Rockford, IL, USA), and luminescence was detected with the FluorChem E system (ProteinSimple). The experiments were performed in triplicate, and band intensities were quantified with AlphaView Analysis software (Cell Biosciences, Santa Clara, CA, USA).

    Statistical analysis

    All data are presented as the mean ± SEM. Statistical analyses were performed with SPSS 19.0 software (IBM China Company Limited, Beijing, China). A one-way analysis of variance with Fisher’s least significant differencepost hoctest or Student’st-test (unpaired) was used to compare group values. A value ofP< 0.05 was considered statistically significant (two-sided).

    Results

    Distribution of catecholaminergic nerve terminals in the hippocampal formation

    We used immunofluorescence with an antibody against TH to characterize the distribution of catecholaminergic nerve terminals within the hippocampal formation. The catecholaminergic nerve terminals formed a dense fiber network that was not uniformly distributed within the various layers of the hippocampus or the DG (Figure 2A, B). However,it was difficult to correlate the location of the fibers with hippocampal subregions, such as the stratum pyramidale or stratum radiatum. The network was diffuse and did not colocalize with dendrites or cell bodies. TH is the rate limiting enzyme in the synthesis of catecholamines, hydroxylating L-tyrosine to L-3,4,-dihydroxyphenylalanine, which is then sequentially converted to dopamine and noradrenaline.Therefore, the TH immunoreactivity identifies either dopaminergic or noradrenergic fibers. Smith and Greene found that dopaminergic fibers were sparsely distributed within the hippocampus and that the majority of detectable fibers were actually noradrenergic nerve terminals primarily originating from the locus coeruleus (Collier et al., 2004; Smith and Greene, 2012; Takeuchi et al., 2016).

    TH levels in catecholaminergic fibers of the hippocampal formation several days after MPP+ administration

    The effects of intracerebroventricularly administered MPP+on TH levels in catecholaminergic nerve terminals in the hippocampal formation were analyzed by immunofluorescence and western blot assay 5 days after the MPP+injection(Figure 3). Fluorescent fibers in the images were isolated using threshold operators in ImageJ software, and the size of the labeled area was measured. The area was then normalized to the total area of the region of interest. The neurotoxin evoked a significant reduction in detectable fibers 6 days after intracerebroventricular MPP+administration (Figure 3B). The ratio of the TH-positive area to the area of the total hippocampal section was 0.0559 ± 0.0050 in the saline group and 0.0261 ± 0.0051 in the MPP+group. These results demonstrate that intracerebroventricular administration of MPP+significantly reduces TH levels in the hippocampus.Whereas it could not be found that specific areas within the hippocampus remained unaffected, intact TH-positive terminals were observed in the stratum radiatum, subiculum and entorhinal cortex (right, white arrows; Figure 3A). The immunofluorescence images in Figure 3A1 and 3A2 show TH-positive fibers and their distribution in the DG, CA1 and CA3 areas at high magnification. It is unknown whether these remaining fibers are dopaminergic or noradrenergic. It should be noted that the hilus in the DG, normally characterized by a dense network of catecholaminergic fibers, was nearly devoid of TH-positive fibers (Figure 3A1).

    To further characterize the effects of MPP+on TH levels in the hippocampus, we performed western blot assay. This revealed a significant difference in TH levels between the saline and MPP+groups (Figure 3C). However, it is unclear whether this indicates axonopathy, leading to the degeneration and loss of nerve terminals, or just a reduction in TH levels.

    Effects of BDNF and MPP+ on TH-positive terminals in the striatum and neurons in the SN

    To examine if a single intracerebroventricular MPP+administration induces dopaminergic cell death in regions linked to Parkinson’s disease, an immunohistochemical analysis of TH-positive neurons in the SN and dopaminergic termi-nals in the striatum was performed 5 days after injection of MPP+. As illustrated in Figure 4, MPP+significantly reduced the number of dopaminergic neurons in the SN. The number of TH-immunoreactive neurons in the SN was 3310 ±114 in the saline group and 2600 ± 221 in the MPP+group(Figure 4A, C). We next examined whether intracerebroventricular BDNF injection 1 day after MPP+administration was neuroprotective. A single BDNF administration did not alter the number of TH-immunoreactive neurons in the SN(Figure 4A, C). The number of TH-immunoreactive neurons in the SN was 3337 ± 127 in the BDNF group and 2459± 128 in the MPP+/BDNF group. One-way analysis of variance revealed a significant difference in TH signal among the groups (F(3,18) = 9.57,P= 0.0005). Fisher’s least significant difference test indicated significant differences between the groups, except for the saline groupvs. the BNDF group and the MPP+groupvs. the MPP+/BDNF group (Figure 4C). These results indicate that intracerebroventricular administration of MPP+induced a significant reduction in TH-immunoreactive neurons in the SN and that BDNF did not attenuate this effect of MPP+.

    In the striatum, TH levels were not uniformly reduced and were higher near the lateral ventricle. Therefore, the difference was expressed as the ratio of the signal intensity between the striatum near the ventricle and that in the lateral parts of the striatum. MPP+had a significant effect on the striatum (Figure 4B, D). This suggests that there is an MPP+concentration gradient from the lateral ventricle to the striatum, a concept that has been proposed previously for intracerebroventricular drug administration for the hippocampus (Valvassori et al., 2015). In addition, the findings indicate that the dose of MPP+used in the present study is sufficient to induce changes in TH levels and the degeneration of SN neurons.

    In contrast to the SN, BDNF increased slightly, but significantly, the TH ratio and reduced the MPP+-induced loss of TH. The striatal TH signal intensity ratio was significantly higher in the MPP+/BDNF group compared with the MPP+group. The TH signal intensity ratio in the nerve terminals in the striatum was 0.89 ± 0.01 in the saline group (n= 4),0.98 ± 0.01 in the BDNF group (n= 4), 0.71 ± 0.03 in the MPP+group (n= 4), and 0.82 ± 0.02 in the MPP+/BDNF group (n= 5). One-way analysis of variance revealed a significant difference in TH signal among the groups (F(3,13)= 26.3,P< 0.0001), and Fisher’s least significant difference test indicated significant differences between the groups (P<0.0001), except for the saline groupvs. the BDNF group and the saline groupvs. the MPP+/BNDF group (Figure 4D).The findings indicate that BDNF significantly attenuates the effect of MPP+on striatal TH expression. Photomicrographs of TH-immunoreactive structures in the striatum and SN are presented in Figure 4A, B.

    Neurogenesis

    There is emerging evidence that dopamine levels regulate neurogenesis not only in the substantia nigra but also in other brain areas such as the hippocampus, subventricular area and striatum. In addition, it has been shown for intraperitoneally administered MPTP that degeneration of the dopaminergic system can enhance neurogenesis in a time-dependent manner. However, not much information is available on the effects of intraperitoneally administered MPP+on neurogenesis. Therefore, we next examined whether a change in the rate of neurogenesis occurs several days after saline, MPP+or MPP+/BDNF administration.As shown in Figure 1A, mitotic cells were labeled by intraperitoneal BrdU administration on day 6. On day 7,BrdU-positive cells in the SGZ and SN were counted. The number of BrdU-positive cells in the SGZ was not altered by the single-dose BDNF administration, but BDNF prevented the MPP+-mediated compensatory increase in neurogenesis(Figure 5B). Representative immunofluorescence images of BrdU-positive cells (red) in the SGZ of the DG are presented in Figure 5A for the different treatment conditions. The number of BrdU-positive cells in the SGZ was 703 ± 64 in the saline group, 730 ± 43 in the BDNF group, 958 ± 50 in the MPP+group, and 775 ± 37 in the MPP+/BDNF group.One-way analysis of variance revealed a significant difference in the number of BrdU-positive cells (F(3,15) = 5.6,P= 0.008), and Fisher’s least significant difference test indicated significant differences for the saline groupvs. the MPP+group, the BDNF groupvs. the MPP+group, and the MPP+groupvs. the MPP+/BDNF group (Figure 5B). The number of BrdU-positive cells in the MPP+group was substantially elevated in comparison with the other groups. While BDNF did not alter the number of BrdU-positive cells in the SGZ,it did so in the MPP+/BDNF group. The results show that intracerebroventricular MPP+strongly induces neurogenesis in the SGZ, and that BDNF diminishes this effect of MPP+.

    The SN is also a site of neurogenesis in adult mice. BDNF substantially reduced the number of BrdU-positive cells 6 days after injection. A similar reduction in the number of mitotic cells was also observed in the MPP+/BDNF group,indicating that BDNF did not suppress the MPP+-induced reduction in neurogenesis in the SN (Figure 5D). The number of BrdU-positive cells in the SN was 1336 ± 159 in the saline group, 416 ± 65 in the BDNF group, 906 ± 139 in the MPP+group, and 266 ± 47 in the MPP+/BDNF group. Oneway analysis of variance revealed a significant difference in the number of BrdU-positive cells among groups (F(3, 13)=18.7,P< 0.0001), and Fisher’s least significant difference test indicated significant differences (P< 0.0001) for the saline groupvs. the BDNF group and the saline groupvs. the MPP+/BDNF group. There were also significant differences between the other groups, except for the BDNF groupvs. the MPP+/BDNF group (Figure 5D). Representative immunofluorescence images of BrdU-positive (red) and TH-immunoreactive cells (green) in the SN are presented in Figure 5C for the different conditions.

    Discussion

    In this study, the dense network of TH-immunoreactive fibers in the hippocampus and DG were sensitive to a single dose of intracerebroventricularly-administered MPP+. In addition, a loss of dopaminergic cells was observed in the SN, as well as a reduction in TH-immunoreactive fibers in the striatum adjacent to the lateral ventricle. MPP+altered the number of BrdU-positive cells in the SN and the SGZ,and intracerebroventricularly-injected BDNF blocked the increase in BrdU-positive cells in the SGZ but not the reduction in the SN. BDNF alone strongly reduced the number of BrdU-positive cells in the SN.

    Very little is known of the dense network of TH-positive nerve terminals within the hippocampus and the DG (Smith and Greene, 2012). In many studies, TH has been used as a marker of dopaminergic fibers (Liang et al., 2016; Wu et al.,2016); however, specific retrograde or anterograde labeling of neurons in the SN or ventral tegmental area revealed low and non-uniform innervation within the septotemporal axis of the hippocampus (Gasbarri et al., 1997). In addition,dopamine receptors are anatomically separated from dopaminergic terminals, making it difficult to correlate function with anatomy. Nonetheless, the dense nerve terminal network revealed by TH immunofluorescence might represent the neural substrate of various hippocampal functions.Indeed, it has been shown that TH-positive nerve terminals from the locus coeruleus innervate the hippocampus and are capable of releasing dopamine under certain conditions(Smith and Greene, 2012). Because TH is the rate limiting enzyme in catecholamine synthesis, anti-TH staining will reveal not only dopaminergic fibers but also noradrenergic fibers (Smith and Greene, 2012). Here, we did not examine the distribution of dopamine transporter or noradrenaline transporter-containing fibers. However, Smith and Greene(2012) clearly identified the sparse distribution within the hippocampus, making it very likely that most detected fibers represent noradrenergic nerve terminals.

    A single MPP+administration into the lateral ventricle was sufficient to induce cell death within the SN and a reduction in TH immunoreactivity in the parts of the striatum in close proximity to the lateral ventricle. Western blot assay confirmed that TH levels in the hippocampus and the DG were reduced. However, selectivity of MPP+for specific fibers within the hippocampus could not be detected, although it was previously hypothesized that dopaminergic fibers in the stratum pyramidale would primarily be affected (Smith and Greene, 2012). It remains unclear how MPP+evokes a reduction in TH levels in noradrenergic fibers, because they do not contain the dopamine transporter considered necessary for the detrimental effects of MPTP and MPP+to manifest in neurons. However, in our previous study on the acute effects of MPP+, a difference in the effects of MPTP and MPP+on hippocampal synaptic transmission was found. Specifically,the effect of MPTP, but not that of MPP+, on hippocampal synaptic transmission was dependent on the activation of dopamine receptors. Further study is needed to clarify the involvement of the noradrenergic system in the effects of MPP+on hippocampal synaptic transmission.

    The DG is one of the most active areas of neurogenesis and neural differentiation in the adult mouse brain, and it is severely affected in Parkinson’s disease (Sairanen et al., 2005;Marxreiter et al., 2013; Schlachetzki et al., 2016). Within 7 days of MPP+administration, there was a substantial reduction in BrdU-positive cells in the SN, but notably, there was an increase in BrdU-positive cells in the SGZ. These findings are in agreement with studies on the effect of MPTP on adult neurogenesis in the SGZ and on the proliferation of newborn cells within the DG (Park and Enikolopov, 2010;Lesemann et al., 2012; Schlachetzki et al., 2016). Klein et al. (2014) found that the number of BrdU- and neuronal marker-positive cells increased by the sixth day after MPTP administration, although only small changes in the number of BrdU-positive cells were observed (Klein et al., 2014). All of these studies used intraperitoneal MPTP administration,and different MPTP doses and administration protocols were used. There are very few studies on the effects of intracerebroventricularly-administered MPP+on neurogenesis.Furthermore, it remains unclear how denervation of dopaminergic fibers impacts neurogenesis in the SGZ (Park and Enikolopov, 2010; Tapia-Bustos et al., 2017) or the subventricular zone (Freundlieb et al., 2006). The mechanisms by which dopamine affects the division of neural precursors are still insufficiently understood but may involve dopamine signaling in dividing cells and compensatory mechanisms that are activated during neurogenesis (Peng et al., 2008;Park and Enikolopov, 2010). Since the initial observation of a dense network of TH-positive nerve terminals in the hippocampus and the observation that the majority of these TH-positive fibers indicate that these are noradrenergic(Smith and Greene, 2012), investigators have sought to examine the effects of noradrenalin depletion on neurogenesis in the hippocampus, adding further complexity to standard Parkinson’s disease models (Borodovitsyna et al., 2017;Braun et al., 2017; Moreno-Castilla et al., 2017).

    Based on the premise that the observed neurogenesis in the SGZ after MPP+administration might be enhanced by neurotrophic factors, we evaluated the effects of BDNF on neurogenesis in the SN and SGZ. BDNF can promote dopaminergic cell development, which might promote the restoration of dopaminergic function (Mao and Wang, 2003).Some drugs for treating depression and Parkinson’s disease act through the BDNF/TrkB signaling pathways (Nie et al.,2015; Zhu et al., 2015; Pollock et al., 2016). However, we found that BDNF administration 1 day after MPP+injection did not induce neurogenesis in the SGZ but prevented the increase in BrdU-positive cells after MPP+administration.Moreover, BDNF administration did not promote, but rather inhibited, neurogenesis in the SN. It is possible that the survival of newborn cells that migrated to the SN decreased after the administration of MPP+or BDNF or that a transient increase in the proliferation of precursors did not result in increased net neurogenesis (Lazarov and Hollands,2016). Other studies have shown that growth factors such as epidermal growth factor and fibroblast growth factor 2 promote the maintenance of adult neural stem cells and cell proliferation (Zhao et al., 2008; Usui et al., 2017). It remains unknown whether noradrenergic fibers innervating the hippocampus from the locus coeruleus have an impact on neurogenesis.

    In summary, a dose of MPP+that causes cell death in the SN reduced TH levels in catecholaminergic nerve terminals in the striatum and hippocampus. In addition, it promoted neurogenesis in the hippocampus but not the SN. Because most TH-positive nerve terminals in the hippocampus are noradrenergic, our findings suggest that MPP+might also interfere with the noradrenergic system.

    Author contributions:JFC and TB designed experiments and graphs and wrote the paper. JFC conducted and analyzed experiments. MW and YHZ analyzed brain sections. All authors approved the final version of this paper.

    Conflicts of interest:We declare that we have no conflict of interest.

    Financial support:This work was supported by the National Natural Science Foundation of China, No. 31320103906. The funding body played no role in the study design, in the collection, analysis and interpretation of data, in the writing of the paper, and in the decision to submit the paper for publication.

    Research ethics:All studies and individual protocols were conducted in accordance with the ethical standards of the Care, Welfare and Treatment of Laboratory Animals and were reviewed by the ethical review process at the Institutes of Brain Science and State Key Laboratory of Medical Neurobiology of Fudan University, Shanghai, China(approval No. 31320103906).

    Data sharing statement:Datasets analyzed during the current study are available from the corresponding author on reasonable request.

    Plagiarism check:Checked twice by iThenticate.

    Peer review:Externally peer reviewed.

    Open access statement:This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

    Bellucci A, Antonini A, Pizzi M, Spano P (2017) The end is the Beginning: Parkinson’s disease in the light of brain imaging. Front Aging Neurosci 9:330.

    Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ (2008) Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol 587:90-98.

    Binukumar BK, Pant HC (2016) TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson’s disease. Neural Regen Res 11:698-701.

    Borodovitsyna O, Flamini M, Chandler D (2017) Noradrenergic modulation of cognition in health and disease. Neural Plast doi:10.1155/2017/603147.

    Braun DJ, Kalinin S, Feinstein DL (2017) Conditional depletion of hippocampal brain-derived neurotrophic factor exacerbates neuropathology in a mouse model of Alzheimer’s disease. ASN Neuro doi: 10.1177/1759091417696161.

    Collier TJ, Greene JG, Felten DL, Stevens SY, Collier KS (2004) Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats.Neurobiol Aging 25:209-221.

    Danielson NB, Kaifosh P, Zaremba JD, Lovett-Barron M, Tsai J,Denny CA, Balough EM, Goldberg AR, Drew LJ, Hen R, Losonczy A, Kheirbek MA (2016) Distinct contribution of adult-born hippocampal granule cells to context encoding. Neuron 90:101-112.

    Deltheil T, Tanaka K, Reperant C, Hen R, David DJ, Gardier AM(2009) Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. Int J Neuropsychopharmacol 12:905-915.

    Dong LD, Chen J, Li F, Gao F, Wu J, Miao Y, Wang Z (2013) Enhanced expression of NR2B subunits of NMDA receptors in the inherited glaucomatous DBA/2J mouse retina. Neural Plast doi:10.1155/2013/670254.

    Ermine CM, Wright JL, Frausin S, Kauhausen JA, Parish CL, Stanic D,Thompson LH (2018) Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson’s disease and the impact on hippocampal neurogenesis. Hippocampus doi: 10.1002/hipo.22835.

    Espinosa-Oliva AM, de Pablos RM, Santiago M (2014) In vivo effect of apomorphine and haloperidol on MPP neurotoxicity. Pharmacology 93:101-107.

    Farzanehfar P (2018) Comparative review of adult midbrain and striatum neurogenesis with classical neurogenesis. Neurosci Res. doi:10.1016/j.neures.2018.01.002.

    Freundlieb N, Francois C, Tande D, Oertel WH, Hirsch EC,Hoglinger GU (2006) Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci 26:2321-2325.

    Gasbarri A, Sulli A, Packard MG (1997) The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry 21:1-22.

    Geed M, Garabadu D, Ahmad A, Krishnamurthy S (2014) Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol Biochem Behav 117:92-103.

    Hu YS, Long N, Pigino G, Brady ST, Lazarov O (2013) Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3beta, neurotrophin-3 and CREB signaling. PLoS One 8:e64460.

    Huang Y, Chen J, Chen Y, Zhuang Y, Sun M, Behnisch T (2015) The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) alters hippocampal excitatory synaptic transmission by modulation of the GABAergic system. Front Cell Neurosci 9:299.

    Jung UJ, Jeon MT, Choi MS, Kim SR (2014) Silibinin attenuates MPP(+)-induced neurotoxicity in the substantia nigra in vivo. J Med Food 17:599-605.

    Kalia LV (2018) Biomarkers for cognitive dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 46 Suppl 1:S19-S23.

    Kim YK, Lim HH, Song YK, Lee HH, Lim S, Han SM, Kim CJ (2005)Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett 384:133-138.

    Klein C, Hain EG, Braun J, Riek K, Mueller S, Steiner B, Sack I (2014)Enhanced adult neurogenesis increases brain stiffness: in vivo magnetic resonance elastography in a mouse model of dopamine depletion. PLoS One 9:e92582.

    Kohl Z, Ben Abdallah N, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, Muller CP, Riess O, Masliah E, Nuber S, Winkler J (2016) Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC alpha-synuclein transgenic rat model of Parkinson’s disease. Neurobiol Dis 85:206-217.

    Kong XY, Cai Z, Pan L, Zhang L, Shu J, Dong YL, Yang N, Li Q,Huang XJ, Zuo PP (2008) Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice.Brain Res 1205:108-115.

    Lazarov O, Hollands C (2016) Hippocampal neurogenesis: Learning to remember. Prog Neurobiol 138-140:1-18.

    Lee HJ, Lim IJ, Lee MC, Kim SU (2010) Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 88:3282-3294.

    Lesemann A, Reinel C, Huhnchen P, Pilhatsch M, Hellweg R, Klaissle P, Winter C, Steiner B (2012) MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice. Brain Res 1457:51-69.

    Liang JQ, Wang L, He JC, Hua XD (2016) Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra. Neural Regen Res 11:101-106.

    Liu Q, Xu Y, Wan W, Ma Z (2018) An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice. J Neural Transm (Vienna) 125:203-210.

    Mao L, Wang JQ (2003) Adult neural stem/progenitor cells in neurodegenerative repair. Sheng Li Xue Bao 55:233-244.

    Marxreiter F, Regensburger M, Winkler J (2013) Adult neurogenesis in Parkinson’s disease. Cell Mol Life Sci 70:459-473.

    Medina JH (2018) Neural, cellular and molecular mechanisms of active forgetting. Front Syst Neurosci doi: 10.3389/fnsys.2018.00003.eCollection 2018.

    Moreno-Castilla P, Perez-Ortega R, Violante-Soria V, Balderas I,Bermudez-Rattoni F (2017) Hippocampal release of dopamine and norepinephrine encodes novel contextual information. Hippocampus 27:547-557.

    Nie S, Xu Y, Chen G, Ma K, Han C, Guo Z, Zhang Z, Ye K, Cao X(2015) Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Neuropharmacology 99:448-458.

    Park JH, Enikolopov G (2010) Transient elevation of adult hippocampal neurogenesis after dopamine depletion. Exp Neurol 222:267-276.

    Paul R, Choudhury A, Kumar S, Giri A, Sandhir R, Borah A (2017)Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress. PLoS One 12:e0171285.

    Pencea V, Bingaman KD, Wiegand SJ, Luskin MB (2001) Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum,septum, thalamus, and hypothalamus. J Neurosci 21:6706-6717.

    Peng J, Xie L, Jin K, Greenberg DA, Andersen JK (2008) Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Neuroscience 153:664-670.

    Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106:589-601.

    Pfeiffer RF (2016) Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 22:S119-S122.

    Pollock K et al. (2016) Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington’s disease mouse models. Mol Ther 24:965-977.

    Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005)Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25:1089-1094.

    Salvi R, Steigleder T, Schlachetzki JC, Waldmann E, Schwab S, Winner B, Winkler J, Kohl Z (2016) Distinct effects of chronic dopaminergic stimulation on hippocampal neurogenesis and striatal doublecortin expression in adult mice. Front Neurosci 10:77.

    Santiago M, Machado A, Cano J (2001) Validity of a quantitative technique to study striatal dopaminergic neurodegeneration by in vivo microdialysis. J Neurosci Methods 108:181-187.

    Santos DB, Colle D, Moreira EL, Hort MA, Godoi M, Le Douaron G,Braga AL, Assreuy J, Michel PP, Prediger RD, Raisman-Vozari R,Farina M (2017) Succinobucol, a non-statin hypocholesterolemic drug, prevents premotor symptoms and nigrostriatal neurodegeneration in an experimental model of Parkinson’s disease. Mol Neurobiol 54:1513-1530.

    Schlachetzki JC, Grimm T, Schlachetzki Z, Ben Abdallah NM, Ettle B,Vohringer P, Ferger B, Winner B, Nuber S, Winkler J (2016) Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of alpha-synuclein. J Neurosci Res 94:62-73.

    Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson’s disease. J Neural Transm (Vienna) 108:1263-1282.

    Smith CC, Greene RW (2012) CNS dopamine transmission mediated by noradrenergic innervation. J Neurosci 32:6072-6080.

    Sonsalla PK, Zeevalk GD, German DC (2008) Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson’s disease. Parkinsonism Relat Disord 14 Suppl 2:S116-118.

    Steffen V, Santiago M, de la Cruz CP, Revilla E, Machado A, Cano J (1995) Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine. Hum Exp Toxicol 14:865-871.

    Takeuchi T, Duszkiewicz AJ, Sonneborn A, Spooner PA, Yamasaki M,Watanabe M, Smith CC, Fernandez G, Deisseroth K, Greene RW,Morris RG (2016) Locus coeruleus and dopaminergic consolidation of everyday memory. Nature 537:357-362.

    Tapia-Bustos A, Perez-Lobos R, Vio V, Lespay-Rebolledo C, Palacios E, Chiti-Morales A, Bustamante D, Herrera-Marschitz M, Morales P (2017) Modulation of postnatal neurogenesis by perinatal asphyxia: effect of D1 and D2 dopamine receptor agonists. Neurotox Res 31:109-121.

    Usui T, Sakurai M, Kawasaki H, Ohama T, Yamawaki H, Sato K(2017) Establishment of a novel three-dimensional primary culture model for hippocampal neurogenesis. Physiol Rep doi: 10.14814/phy2.13318.

    Valvassori SS, Arent CO, Steckert AV, Varela RB, Jornada LK, Tonin PT, Budni J, Mariot E, Kapczinski F, Quevedo J (2015) Intracerebral administration of BDNF protects rat brain against oxidative stress induced by ouabain in an animal model of mania. Mol Neurobiol 52:353-362.

    Wang M, Li D, Yun D, Zhuang Y, Repunte-Canonigo V, Sanna PP,Behnisch T (2017) Translation of BDNF-gene transcripts with short 3’ UTR in hippocampal CA1 neurons improves memory formation and enhances synaptic plasticity-relevant signaling pathways. Neurobiol Learn Mem 138:121-134.

    Wu YD, Liang PR, Long DY, Gao BM (2016) Effects of Ginkgo biloba Pingchan Recipe on loss and apoptosis of dopamine neurons in mouse models of Parkinson’s disease. Zhongguo Zuzhi Gongcheng Yanjiu 20:7327-7333.

    Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132:645-660.

    Zhu G, Chen Y, Huang Y, Li Q, Behnisch T (2011) MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity. Toxicol Appl Pharmacol 254:332-341.

    Zhu G, Huang Y, Chen Y, Zhuang Y, Behnisch T (2012) MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors. J Neurochem 122:582-593.

    Zhu G, Li J, He L, Wang X, Hong X (2015) MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway. Br J Pharmacol 172:2354-2368.

    国产伦一二天堂av在线观看| 国产高清激情床上av| av在线播放免费不卡| 午夜福利免费观看在线| 精品久久久久久电影网| 美女福利国产在线| av天堂在线播放| 啦啦啦 在线观看视频| 午夜福利在线观看吧| av片东京热男人的天堂| 午夜福利影视在线免费观看| 亚洲少妇的诱惑av| 美女高潮喷水抽搐中文字幕| 久久午夜亚洲精品久久| 制服人妻中文乱码| 欧美乱码精品一区二区三区| 天天躁夜夜躁狠狠躁躁| 国产精品日韩av在线免费观看 | 两性夫妻黄色片| 法律面前人人平等表现在哪些方面| 欧美人与性动交α欧美软件| 国产xxxxx性猛交| 午夜福利免费观看在线| 欧美丝袜亚洲另类 | 日本免费一区二区三区高清不卡 | 这个男人来自地球电影免费观看| 国产高清国产精品国产三级| 变态另类成人亚洲欧美熟女 | 交换朋友夫妻互换小说| 99久久综合精品五月天人人| 亚洲午夜精品一区,二区,三区| 精品久久久久久,| 亚洲人成77777在线视频| 99精品久久久久人妻精品| 精品午夜福利视频在线观看一区| 久久久国产成人精品二区 | videosex国产| 久久久水蜜桃国产精品网| 在线观看一区二区三区激情| 80岁老熟妇乱子伦牲交| 在线天堂中文资源库| 91av网站免费观看| 久久香蕉激情| 国产激情久久老熟女| 脱女人内裤的视频| 99国产精品一区二区三区| 亚洲 欧美 日韩 在线 免费| 亚洲精品在线观看二区| 国产又色又爽无遮挡免费看| 天堂√8在线中文| 欧美日韩乱码在线| 91国产中文字幕| 亚洲成国产人片在线观看| 国产av一区在线观看免费| 欧美乱色亚洲激情| 亚洲第一av免费看| 18禁美女被吸乳视频| 欧美中文日本在线观看视频| 亚洲精品一卡2卡三卡4卡5卡| 一区福利在线观看| a级毛片在线看网站| 日本三级黄在线观看| 精品福利观看| 亚洲av成人av| 国产极品粉嫩免费观看在线| 日韩免费高清中文字幕av| 亚洲精品一区av在线观看| 淫秽高清视频在线观看| 亚洲成a人片在线一区二区| 9191精品国产免费久久| 丁香欧美五月| 日韩人妻精品一区2区三区| 日本三级黄在线观看| 一级黄色大片毛片| 长腿黑丝高跟| 99久久精品国产亚洲精品| 精品久久久精品久久久| 亚洲成人精品中文字幕电影 | 亚洲 欧美一区二区三区| 12—13女人毛片做爰片一| 99在线人妻在线中文字幕| 久9热在线精品视频| 窝窝影院91人妻| 自线自在国产av| 国产成人精品在线电影| av网站在线播放免费| 精品福利观看| 国产欧美日韩精品亚洲av| 99香蕉大伊视频| 国产成人免费无遮挡视频| 999久久久国产精品视频| 色综合站精品国产| 性欧美人与动物交配| 久久国产精品人妻蜜桃| 天堂俺去俺来也www色官网| 久久狼人影院| 久久人妻福利社区极品人妻图片| 精品午夜福利视频在线观看一区| 精品国产亚洲在线| 啦啦啦 在线观看视频| x7x7x7水蜜桃| 国产精品乱码一区二三区的特点 | 国产精品 国内视频| 在线播放国产精品三级| 黄色 视频免费看| 国产一区二区激情短视频| 美女 人体艺术 gogo| 午夜日韩欧美国产| 一区二区日韩欧美中文字幕| 国产熟女午夜一区二区三区| 国产免费男女视频| 国产一卡二卡三卡精品| 久久这里只有精品19| 亚洲欧美一区二区三区久久| 在线天堂中文资源库| 国产欧美日韩一区二区精品| 国产亚洲精品一区二区www| 亚洲第一av免费看| 波多野结衣一区麻豆| 中文字幕高清在线视频| 午夜a级毛片| 99riav亚洲国产免费| 怎么达到女性高潮| 亚洲国产精品sss在线观看 | 免费在线观看视频国产中文字幕亚洲| 精品一区二区三卡| 男人操女人黄网站| 欧美乱码精品一区二区三区| 黄片小视频在线播放| 99在线视频只有这里精品首页| 久久久久久久久中文| 亚洲欧美日韩无卡精品| 国产精华一区二区三区| 欧美乱码精品一区二区三区| 国产又色又爽无遮挡免费看| 欧美成狂野欧美在线观看| 怎么达到女性高潮| 国产野战对白在线观看| 99riav亚洲国产免费| 国产激情欧美一区二区| 99re在线观看精品视频| 高清毛片免费观看视频网站 | 午夜免费观看网址| 国产极品粉嫩免费观看在线| 国产精品乱码一区二三区的特点 | 成年人黄色毛片网站| 麻豆一二三区av精品| 在线视频色国产色| 中国美女看黄片| 久久久久久久久免费视频了| 免费少妇av软件| www.www免费av| 国产激情欧美一区二区| 在线观看一区二区三区激情| av福利片在线| 一二三四在线观看免费中文在| 午夜福利,免费看| 热99re8久久精品国产| 又黄又粗又硬又大视频| 99国产精品免费福利视频| 精品无人区乱码1区二区| 久久精品亚洲熟妇少妇任你| 久久香蕉国产精品| 多毛熟女@视频| 不卡一级毛片| 欧美在线一区亚洲| 在线观看免费高清a一片| 国产在线观看jvid| 欧美精品一区二区免费开放| 在线十欧美十亚洲十日本专区| 精品国产美女av久久久久小说| 日韩有码中文字幕| 精品少妇一区二区三区视频日本电影| 免费高清在线观看日韩| 最近最新中文字幕大全电影3 | 亚洲国产欧美网| 国产不卡一卡二| 成年人黄色毛片网站| av电影中文网址| 另类亚洲欧美激情| 狂野欧美激情性xxxx| 亚洲三区欧美一区| 性色av乱码一区二区三区2| 伦理电影免费视频| 久久国产乱子伦精品免费另类| 一级,二级,三级黄色视频| 人人澡人人妻人| 亚洲精品成人av观看孕妇| 久99久视频精品免费| 热99re8久久精品国产| 91老司机精品| 久热爱精品视频在线9| 亚洲欧美日韩无卡精品| 成年人免费黄色播放视频| 后天国语完整版免费观看| 搡老乐熟女国产| 免费在线观看视频国产中文字幕亚洲| 国产精品影院久久| 国产一区二区在线av高清观看| a级毛片在线看网站| av网站在线播放免费| 麻豆成人av在线观看| 女生性感内裤真人,穿戴方法视频| 中文字幕色久视频| 精品电影一区二区在线| 午夜福利在线观看吧| 看黄色毛片网站| 亚洲片人在线观看| 午夜精品久久久久久毛片777| 国产精品久久久久成人av| 人人妻人人爽人人添夜夜欢视频| 精品国产一区二区久久| 成人特级黄色片久久久久久久| 99精国产麻豆久久婷婷| 高潮久久久久久久久久久不卡| 欧美日本亚洲视频在线播放| av福利片在线| 日本黄色视频三级网站网址| 日韩av在线大香蕉| 一区二区三区国产精品乱码| 国产精品免费一区二区三区在线| 亚洲一区高清亚洲精品| 午夜视频精品福利| 大型av网站在线播放| 日韩大尺度精品在线看网址 | 亚洲成人国产一区在线观看| 久久九九热精品免费| 亚洲精品国产一区二区精华液| 欧美人与性动交α欧美软件| 99久久久亚洲精品蜜臀av| 久久精品国产清高在天天线| 国产97色在线日韩免费| 国产欧美日韩一区二区三区在线| 又大又爽又粗| 亚洲国产精品合色在线| 久久香蕉国产精品| 亚洲在线自拍视频| 国产又色又爽无遮挡免费看| 首页视频小说图片口味搜索| 天天躁夜夜躁狠狠躁躁| 欧美成狂野欧美在线观看| www日本在线高清视频| 欧美激情极品国产一区二区三区| 久久人妻av系列| 亚洲成人精品中文字幕电影 | 国产精品1区2区在线观看.| 国产免费现黄频在线看| 淫妇啪啪啪对白视频| 99re在线观看精品视频| 国产精品亚洲av一区麻豆| 亚洲一区二区三区色噜噜 | 好看av亚洲va欧美ⅴa在| 亚洲av美国av| 精品欧美一区二区三区在线| 国产男靠女视频免费网站| 午夜免费激情av| 757午夜福利合集在线观看| 女生性感内裤真人,穿戴方法视频| 黑人猛操日本美女一级片| 涩涩av久久男人的天堂| av网站免费在线观看视频| 99久久99久久久精品蜜桃| 深夜精品福利| 男女高潮啪啪啪动态图| 一区福利在线观看| 欧美成人免费av一区二区三区| 午夜视频精品福利| 男人操女人黄网站| 久久久久久免费高清国产稀缺| 亚洲国产精品一区二区三区在线| 精品国产乱子伦一区二区三区| 久久精品aⅴ一区二区三区四区| 两人在一起打扑克的视频| 999精品在线视频| a级毛片在线看网站| 久久精品亚洲精品国产色婷小说| 欧美激情极品国产一区二区三区| 黄色怎么调成土黄色| 男人舔女人下体高潮全视频| 可以免费在线观看a视频的电影网站| 精品电影一区二区在线| 别揉我奶头~嗯~啊~动态视频| 欧美日韩av久久| 在线天堂中文资源库| 级片在线观看| 精品人妻在线不人妻| 夜夜夜夜夜久久久久| 国产精品综合久久久久久久免费 | 人人妻人人澡人人看| 亚洲欧美精品综合一区二区三区| 亚洲七黄色美女视频| 亚洲av片天天在线观看| 国产三级黄色录像| 日韩大尺度精品在线看网址 | 国产精品成人在线| 亚洲 欧美 日韩 在线 免费| 午夜免费激情av| 成年版毛片免费区| 欧美成人性av电影在线观看| 黑人操中国人逼视频| 国产黄a三级三级三级人| 久久热在线av| 免费av毛片视频| 精品午夜福利视频在线观看一区| 亚洲第一av免费看| 99久久综合精品五月天人人| 久久国产精品男人的天堂亚洲| 亚洲色图 男人天堂 中文字幕| 久久国产精品影院| 亚洲五月天丁香| www日本在线高清视频| 女生性感内裤真人,穿戴方法视频| 亚洲情色 制服丝袜| 午夜福利一区二区在线看| 精品欧美一区二区三区在线| 国产又爽黄色视频| 久久草成人影院| 免费看a级黄色片| 在线观看免费午夜福利视频| 999久久久国产精品视频| 久久午夜亚洲精品久久| 欧美亚洲日本最大视频资源| tocl精华| 欧美日韩亚洲高清精品| 免费在线观看黄色视频的| 日韩中文字幕欧美一区二区| 91国产中文字幕| 精品少妇一区二区三区视频日本电影| 这个男人来自地球电影免费观看| 女性被躁到高潮视频| 大陆偷拍与自拍| 久久 成人 亚洲| 欧美日本中文国产一区发布| 一级毛片女人18水好多| 亚洲精品美女久久久久99蜜臀| 亚洲欧洲精品一区二区精品久久久| 国产不卡一卡二| 精品午夜福利视频在线观看一区| 美女午夜性视频免费| 欧美丝袜亚洲另类 | 亚洲性夜色夜夜综合| av国产精品久久久久影院| 深夜精品福利| 日韩大尺度精品在线看网址 | 在线观看日韩欧美| 91字幕亚洲| 午夜精品久久久久久毛片777| 不卡一级毛片| 99精品久久久久人妻精品| 999久久久精品免费观看国产| 国产成人影院久久av| 亚洲欧美日韩另类电影网站| 在线观看午夜福利视频| 欧美成人午夜精品| 中亚洲国语对白在线视频| 97人妻天天添夜夜摸| 日韩av在线大香蕉| 无限看片的www在线观看| 免费高清在线观看日韩| 国产成+人综合+亚洲专区| 国内毛片毛片毛片毛片毛片| 国产1区2区3区精品| 91麻豆精品激情在线观看国产 | 91精品三级在线观看| 国产成人av激情在线播放| 午夜福利,免费看| 亚洲情色 制服丝袜| 亚洲男人天堂网一区| 国产日韩一区二区三区精品不卡| 欧美老熟妇乱子伦牲交| 国产精品 欧美亚洲| 午夜a级毛片| www.精华液| 男女做爰动态图高潮gif福利片 | netflix在线观看网站| 五月开心婷婷网| 男男h啪啪无遮挡| videosex国产| 精品卡一卡二卡四卡免费| 国产精品日韩av在线免费观看 | 欧美激情久久久久久爽电影 | 狂野欧美激情性xxxx| 亚洲第一av免费看| 黑人猛操日本美女一级片| 亚洲国产精品sss在线观看 | 亚洲成人精品中文字幕电影 | 国产精品影院久久| 99久久精品国产亚洲精品| 欧美日本亚洲视频在线播放| 人妻久久中文字幕网| 男人舔女人下体高潮全视频| 午夜成年电影在线免费观看| 久久精品国产清高在天天线| 免费观看精品视频网站| 91成年电影在线观看| 午夜日韩欧美国产| 18禁美女被吸乳视频| 一边摸一边抽搐一进一出视频| 一个人观看的视频www高清免费观看 | 亚洲情色 制服丝袜| 99国产精品免费福利视频| 国产激情欧美一区二区| 99精国产麻豆久久婷婷| 久久久久国产精品人妻aⅴ院| 免费人成视频x8x8入口观看| 又紧又爽又黄一区二区| 国产精品成人在线| 91字幕亚洲| 亚洲成a人片在线一区二区| 亚洲国产毛片av蜜桃av| 免费av中文字幕在线| 国产一卡二卡三卡精品| 可以在线观看毛片的网站| 午夜福利免费观看在线| 欧美性长视频在线观看| 一边摸一边抽搐一进一小说| 欧美日韩黄片免| 久99久视频精品免费| 午夜免费成人在线视频| 老司机福利观看| 国产精品久久久人人做人人爽| 国产人伦9x9x在线观看| 亚洲精品国产精品久久久不卡| 热re99久久国产66热| 日韩欧美免费精品| 一二三四在线观看免费中文在| 亚洲五月婷婷丁香| 嫩草影视91久久| 国产精品亚洲av一区麻豆| 男女下面进入的视频免费午夜 | 大香蕉久久成人网| 国产成人欧美| 极品人妻少妇av视频| 色在线成人网| 黑人猛操日本美女一级片| 99热只有精品国产| 中文字幕高清在线视频| 狠狠狠狠99中文字幕| 无限看片的www在线观看| 免费女性裸体啪啪无遮挡网站| 色婷婷久久久亚洲欧美| 国产成人精品无人区| 嫁个100分男人电影在线观看| 手机成人av网站| 中国美女看黄片| 老汉色∧v一级毛片| 热99re8久久精品国产| 亚洲欧美日韩无卡精品| 级片在线观看| 国产亚洲欧美在线一区二区| 亚洲va日本ⅴa欧美va伊人久久| 母亲3免费完整高清在线观看| 亚洲人成网站在线播放欧美日韩| 制服诱惑二区| 久久人人精品亚洲av| 精品日产1卡2卡| 少妇被粗大的猛进出69影院| av国产精品久久久久影院| 极品教师在线免费播放| 国产精品99久久99久久久不卡| 成年人黄色毛片网站| 亚洲av成人不卡在线观看播放网| 大码成人一级视频| 亚洲精品一二三| 欧美最黄视频在线播放免费 | 中文字幕av电影在线播放| 久久人妻福利社区极品人妻图片| 亚洲欧美精品综合一区二区三区| 99精品久久久久人妻精品| 91成人精品电影| 日本三级黄在线观看| 亚洲精品美女久久久久99蜜臀| 亚洲午夜理论影院| 老鸭窝网址在线观看| 在线观看www视频免费| 99热国产这里只有精品6| 亚洲欧美日韩无卡精品| 久久午夜综合久久蜜桃| 亚洲av日韩精品久久久久久密| 日韩国内少妇激情av| 亚洲精华国产精华精| 成人av一区二区三区在线看| 成年女人毛片免费观看观看9| 午夜福利一区二区在线看| 看免费av毛片| 中文字幕另类日韩欧美亚洲嫩草| 一边摸一边做爽爽视频免费| 国产麻豆69| 久久亚洲精品不卡| 丁香六月欧美| 亚洲欧美一区二区三区黑人| 热re99久久精品国产66热6| 日本vs欧美在线观看视频| 美女午夜性视频免费| 91老司机精品| 少妇裸体淫交视频免费看高清 | 欧美在线一区亚洲| 黄色 视频免费看| 国产单亲对白刺激| 美女高潮喷水抽搐中文字幕| 麻豆一二三区av精品| 99国产精品一区二区蜜桃av| 妹子高潮喷水视频| 久久精品国产99精品国产亚洲性色 | 大型黄色视频在线免费观看| 美女扒开内裤让男人捅视频| 亚洲熟妇熟女久久| 两性午夜刺激爽爽歪歪视频在线观看 | 美国免费a级毛片| 在线观看午夜福利视频| 国产精品影院久久| 法律面前人人平等表现在哪些方面| 日本黄色日本黄色录像| 亚洲自偷自拍图片 自拍| 久久精品91无色码中文字幕| www.自偷自拍.com| 亚洲国产中文字幕在线视频| 一二三四社区在线视频社区8| 咕卡用的链子| 久久久久国内视频| 亚洲少妇的诱惑av| 最新美女视频免费是黄的| 国产精品自产拍在线观看55亚洲| 欧美精品亚洲一区二区| 国产精品美女特级片免费视频播放器 | 99热只有精品国产| 在线观看舔阴道视频| 这个男人来自地球电影免费观看| 婷婷精品国产亚洲av在线| 国产片内射在线| 90打野战视频偷拍视频| 又紧又爽又黄一区二区| 极品人妻少妇av视频| 欧美午夜高清在线| 一区二区三区国产精品乱码| 一级,二级,三级黄色视频| 成人国产一区最新在线观看| 国产精品 欧美亚洲| 视频区欧美日本亚洲| 亚洲欧美精品综合一区二区三区| 国产成人一区二区三区免费视频网站| 国产免费av片在线观看野外av| 99国产精品99久久久久| 18美女黄网站色大片免费观看| 神马国产精品三级电影在线观看 | 女性生殖器流出的白浆| 一二三四在线观看免费中文在| 国产精品秋霞免费鲁丝片| av视频免费观看在线观看| 欧美久久黑人一区二区| 亚洲精品国产精品久久久不卡| 亚洲一卡2卡3卡4卡5卡精品中文| 欧美在线一区亚洲| 少妇 在线观看| 如日韩欧美国产精品一区二区三区| 国产无遮挡羞羞视频在线观看| 国产熟女午夜一区二区三区| 嫩草影视91久久| 久久久国产一区二区| 国产精品免费一区二区三区在线| 免费一级毛片在线播放高清视频 | 国产精品av久久久久免费| 免费日韩欧美在线观看| 亚洲五月婷婷丁香| 99久久人妻综合| 欧洲精品卡2卡3卡4卡5卡区| 长腿黑丝高跟| 老司机深夜福利视频在线观看| 最近最新免费中文字幕在线| 成人av一区二区三区在线看| 亚洲成国产人片在线观看| 免费av毛片视频| 亚洲色图综合在线观看| 亚洲av电影在线进入| 757午夜福利合集在线观看| 青草久久国产| 男女午夜视频在线观看| 日韩欧美在线二视频| 亚洲成av片中文字幕在线观看| 麻豆一二三区av精品| 国内毛片毛片毛片毛片毛片| 一二三四在线观看免费中文在| 亚洲人成电影免费在线| 在线视频色国产色| 在线播放国产精品三级| 天堂√8在线中文| 午夜福利影视在线免费观看| 这个男人来自地球电影免费观看| 成人国产一区最新在线观看| 一级片'在线观看视频| 中文字幕人妻丝袜一区二区| 一本综合久久免费| 嫁个100分男人电影在线观看| 大型黄色视频在线免费观看| bbb黄色大片| 在线观看一区二区三区| 日日夜夜操网爽| 亚洲av第一区精品v没综合| 少妇 在线观看| 无人区码免费观看不卡| 欧美黑人精品巨大| 91精品国产国语对白视频| а√天堂www在线а√下载| 国产视频一区二区在线看| 中文字幕人妻熟女乱码| 国产av在哪里看| 高清在线国产一区| 女性生殖器流出的白浆| 国产免费男女视频| 久久久久九九精品影院| 村上凉子中文字幕在线| 久久午夜综合久久蜜桃| 欧美日韩中文字幕国产精品一区二区三区 | 别揉我奶头~嗯~啊~动态视频| 成人三级黄色视频|